HIV-1 NAT Screening of Plasma at Aventis Behring: HIV-1 vs. HIV Ag

9/13/00


Click here to start


Table of Contents

HIV-1 NAT Screening of Plasma at Aventis Behring: HIV-1 vs. HIV Ag

Test process

3,250,000 Units Tested

Donor Testing

HIV Repository Panels

FDA HIV-1 NAT Panel

Author: Robert J. Kratzel, Ph.D.